Correlation Between Okta and Zealand Pharma
Can any of the company-specific risk be diversified away by investing in both Okta and Zealand Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and Zealand Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and Zealand Pharma AS, you can compare the effects of market volatilities on Okta and Zealand Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of Zealand Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and Zealand Pharma.
Diversification Opportunities for Okta and Zealand Pharma
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Okta and Zealand is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and Zealand Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zealand Pharma AS and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with Zealand Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zealand Pharma AS has no effect on the direction of Okta i.e., Okta and Zealand Pharma go up and down completely randomly.
Pair Corralation between Okta and Zealand Pharma
Given the investment horizon of 90 days Okta is expected to generate 3.74 times less return on investment than Zealand Pharma. But when comparing it to its historical volatility, Okta Inc is 1.18 times less risky than Zealand Pharma. It trades about 0.03 of its potential returns per unit of risk. Zealand Pharma AS is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 19,860 in Zealand Pharma AS on August 25, 2024 and sell it today you would earn a total of 52,790 from holding Zealand Pharma AS or generate 265.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Okta Inc vs. Zealand Pharma AS
Performance |
| Timeline |
| Okta Inc |
| Zealand Pharma AS |
Okta and Zealand Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Okta and Zealand Pharma
The main advantage of trading using opposite Okta and Zealand Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, Zealand Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zealand Pharma will offset losses from the drop in Zealand Pharma's long position.The idea behind Okta Inc and Zealand Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Zealand Pharma vs. Bavarian Nordic | Zealand Pharma vs. Ambu AS | Zealand Pharma vs. Genmab AS | Zealand Pharma vs. ALK Abell AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |